ACM
PFE icon

Arrow Capital Management’s Pfizer PFE Stock Holding History

Arrow Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-23,192
Closed -$775K – 26
2016
Q2 		$775K Sell
23,192
-131,750
-85% -$4.2M 1.26% 15
2016
Q1 		$4.36M Buy
+154,942
New +$4.43M 4.83% 8

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrow Capital Management's PFE Position: Q3 2016 in Review

Arrow Capital Management sold out of Pfizer (PFE) in Q3 2016, closing a stake of 23,192 shares — an estimated $775K sold.

Arrow Capital Management first reported a position in PFE in Q1 2016 and held it in 2 quarters. The position peaked at $4.36M in Q1 2016. 1,964 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Arrow Capital Management reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
  • Arrow Capital Management sold 23,192 Pfizer shares in Q3 2016, an estimated $775K.
  • Arrow Capital Management first reported a position in Pfizer in Q1 2016 and held it in 2 quarters.
  • Arrow Capital Management's Pfizer position peaked at $4.36M in Q1 2016.
  • 1,964 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Arrow Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.